[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"milk-allergy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:milk-allergy":82},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,59],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":26,"conditions":27,"keywords":31,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":47,"lastUpdatePostDateStruct":48,"startDateStruct":51,"completionDateStruct":53,"leadSponsor":55,"locationsCount":58},"100591157",false,"NCT06976775","Comparison Between a Rush and a Conventional Oral Immunotherapy Protocol to Treat Cow's Milk and Hen´s Egg Allergy. CompITO Study","Comparative Analysis Between Two Oral Immunotherapy Schemes in Cow´s Milk and\u002For Hen´s Egg Allergic Children to Improve Treatment Efficiency and Identify Response Biomarkers. CompITO Study","compITO","Inclusion Criteria:\n\n* Patients 6 to 16 years old\n* sIgE levels to milk 0.35 to 35kUA\u002FL for milk allergic subjects and egg 0.35 to 35kUA\u002FL for egg allergic subjects\n* Entry DBPCFC discrete milk eliciting dose (ED)≥ 22.2mg of milk protein and discrete egg ED≥18.5mg of egg protein, that are the population-based reference values for the ED20\n* Having a mild to moderate food allergy severity per DEFASE score (\\\u003C13 points)\n\nExclusion Criteria:\n\n* sIgE levels to milk \\>35kUA\u002FL for milk allergic subjects and egg \\> 35kUA\u002FL for milk allergic subjects\n* Entry DBPCFC discrete milk ED\\\u003C22.2mg of milk protein or discrete egg ED\\\u003C18.5mg of egg protein\n* Entry DBPCFC discrete ED for milk\\>2112mg of milk protein (cumulative amount of 4193,7mg of milk protein) and egg discrete ED\\>1560mg of egg protein (cumulative amount of 3110.8mg of egg protein)\n* Having severe food allergy per DEFASE score (≥13 points)\n* Other exclusion criteria: uncontrolled asthma, FEV1\\\u003C70%, severe atopic dermatitis, Eosinophilic Esophagitis, non-IgE mediated allergy, having started SCIT 3 months before, or SLIT one week before. Pregnancy","ALL","6 Years","16 Years",{"count":20,"type":21},40,"ESTIMATED","INTERVENTIONAL",[24,25],"PHASE2","PHASE3","This study investigates the efficacy and safety of two different OIT schemes to treat milk and egg allergic children",[28,29,30],"Food Allergy in Children","Milk Allergy","Egg Allergy",[32,33,34,35,36,37,38,39,40,41,42,43,44,45],"Food immunotherapy","Allergy","Milk","Egg","Oral immunotherapy","Anaphylaxis","Mast cell activation test","Saliva","Blood","IgE","Food allergy","Sensitization","Children","Pediatric","RECRUITING","2026-02-16",{"date":49,"type":50},"2026-02-18","ACTUAL",{"date":52,"type":50},"2025-06-03",{"date":54,"type":21},"2027-04-30",{"name":56,"class":57},"Pablo Rodríguez del Rio","OTHER",1,{"id":60,"slug":4,"hasResults":10,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":10,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":66,"targetDuration":4,"studyType":68,"phases":4,"briefSummary":69,"conditions":70,"keywords":4,"overallStatus":46,"whyStopped":4,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":58},"100620558","NCT07359183","A Long Term, Observational Follow-Up Study of Children and Young People Who Underwent an 18-Month Course of Oral Immunotherapy Treatment for Peanut, Egg or Milk Allergy (5-15 Years Post-Treatment)","Long Term Outcomes Associated With Attainment of Remission Following Oral Immunotherapy to Peanut, Egg and Cow's Milk (LPEM Study)","LPEM","Inclusion Criteria:\n\n* Previous participant of PEAT, PrEMO, PPOIT-001 or PPOIT-002 parent study\n* Received at least one dose of OIT treatment in the parent study\n* Written informed consent from participant and\u002For parent\u002Fguardian (if below 18 years of age)\n\nExclusion Criteria:\n\n-Have any conditions that, in the opinion of the investigator, precludes participation for reason of safety",{"count":67,"type":21},147,"OBSERVATIONAL","The goal of this observational study is to learn about the long-term outcomes of children and young people who underwent an 18-month course of oral immunotherapy (OIT) treatment for peanut, egg or milk allergy. It aims to:\n\n• Compare long-term changes in health-related quality of life (HRQL) at 5-15 years after stopping OIT in participants who achieved remission and those who did not.\n\nParticipants will attend a single follow-up visit for:\n\n* A blood test\n* Skin prick test (SPT)\n* Allergy questionnaires",[71,72,30,29],"Food Allergies","Peanut Allergies","2026-01-29",{"date":75,"type":50},"2026-02-02",{"date":77,"type":50},"2026-01-13",{"date":79,"type":21},"2027-01",{"name":81,"class":57},"Murdoch Childrens Research Institute",""]